Antipsychotic treatment of very late-onset schizophrenia-like psychosis (ATLAS): a randomised, controlled, double-blind trialRobert Howard, Richard Gray, Craig Ritchie et al.|The Lancet Psychiatry|2018Cited by 66
Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trialPatrick G. Kehoe, Bernadette McGuinness, Nicholas Turner et al.|The Lancet Neurology|2021Cited by 59
Amisulpride for very late-onset schizophrenia-like psychosis: the ATLAS three-arm RCTRobert Howard, Richard Gray, Elizabeth Cort et al.|Health Technology Assessment|2018Cited by 10